Short Interest in Merck KGaA (OTCMKTS:MKKGY) Expands By 710.0%

Merck KGaA (OTCMKTS:MKKGY) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 8,100 shares, a growth of 710.0% from the February 13th total of 1,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 238,300 shares, the days-to-cover ratio is presently 0.0 days.

Merck KGaA Price Performance

Shares of OTCMKTS MKKGY traded up $0.25 during trading hours on Wednesday, hitting $29.30. 80,409 shares of the stock were exchanged, compared to its average volume of 126,898. The company has a market cap of $18.93 billion, a PE ratio of 18.09, a price-to-earnings-growth ratio of 2.05 and a beta of 0.98. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The company’s fifty day simple moving average is $29.26 and its two-hundred day simple moving average is $31.76. Merck KGaA has a 1-year low of $27.68 and a 1-year high of $39.17.

Merck KGaA (OTCMKTS:MKKGY) last issued its quarterly earnings results on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. The company had revenue of $5.78 billion for the quarter, compared to the consensus estimate of $5.40 billion. On average, sell-side analysts predict that Merck KGaA will post 1.87 EPS for the current year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.